fig1
![Leveraging biomimetic synthesis strategy for next-generation dendritic cell nanovaccines](https://image.oaes.cc/2fc1a34c-bb20-4e3d-b18b-ce7884c55855/5214.fig.1.jpg)
Figure 1. (A) Illustration of the process for preparing ASPIRE from DCs. DCNVs have nanoscale size, good stability, and a homing effect, thus enabling ASPIRE to be rapidly enriched in the lymphatic system. (B) Schematic describing ASPIRE for antigen self-presentation and immunosuppression blockade. ASPIRE: Antigen self-presentation and immunosuppression reversal; DCs: dendritic cells. Reproduced with permission. Copyright 2022, Springer Nature.